Literature DB >> 18227422

Long-term outcome in PCNSL patients treated with high-dose methotrexate and deferred radiation.

Elizabeth R Gerstner1, Kathryn A Carson, Stuart A Grossman, Tracy T Batchelor.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18227422      PMCID： PMC4118737          DOI： 10.1212/01.wnl.0000300671.37279.0e

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  4 in total

1.  German Cancer Society Neuro-Oncology Working Group NOA-03 multicenter trial of single-agent high-dose methotrexate for primary central nervous system lymphoma.

Authors:  Ulrich Herrlinger; Martin Schabet; Wolfram Brugger; Rolf-Dieter Kortmann; Wilhelm Küker; Martina Deckert; Corinna Engel; Hans-Jürgen Schmeck-Lindenau; Hans-Günther Mergenthaler; Peter Krauseneck; Christian Benöhr; Christoph Meisner; Otmar D Wiestler; Johannes Dichgans; Lothar Kanz; Michael Bamberg; Michael Weller
Journal:  Ann Neurol       Date:  2002-02       Impact factor: 10.422

2.  Non-Hodgkin's lymphoma of the brain: can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation Therapy Oncology Group (RTOG): RTOG 8315.

Authors:  D F Nelson; K L Martz; H Bonner; J S Nelson; J Newall; H D Kerman; J W Thomson; K J Murray
Journal:  Int J Radiat Oncol Biol Phys       Date:  1992       Impact factor: 7.038

3.  Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group Study 93-10.

Authors:  Lisa M DeAngelis; Wendy Seiferheld; S Clifford Schold; Barbara Fisher; Christopher J Schultz
Journal:  J Clin Oncol       Date:  2002-12-15       Impact factor: 44.544

4.  Treatment of primary CNS lymphoma with methotrexate and deferred radiotherapy: a report of NABTT 96-07.

Authors:  Tracy Batchelor; Kathryn Carson; Alison O'Neill; Stuart A Grossman; Jane Alavi; Pamela New; Fred Hochberg; Regina Priet
Journal:  J Clin Oncol       Date:  2003-03-15       Impact factor: 44.544
  4 in total
  27 in total

1.  Primary CNS lymphoma.

Authors:  Uwe Schlegel
Journal:  Ther Adv Neurol Disord       Date:  2009-03       Impact factor: 6.570

2.  Cognitive functions in primary CNS lymphoma after single or combined modality regimens.

Authors:  Denise D Correa; Weiji Shi; Lauren E Abrey; Lisa M Deangelis; Antonio M Omuro; Mariel B Deutsch; Howard T Thaler
Journal:  Neuro Oncol       Date:  2011-10-19       Impact factor: 12.300

Review 3.  Primary pituitary lymphoma: an update of the literature.

Authors:  A Tarabay; G Cossu; M Berhouma; M Levivier; R T Daniel; M Messerer
Journal:  J Neurooncol       Date:  2016-08-31       Impact factor: 4.130

4.  Initial experience with bendamustine in patients with recurrent primary central nervous system lymphoma: a case report.

Authors:  Jaclyn J Renfrow; Alisha Detroye; Michael Chan; Stephen Tatter; Thomas Ellis; Kevin McMullen; Annette Johnson; Ryan Mott; Glenn J Lesser
Journal:  J Neurooncol       Date:  2012-01-17       Impact factor: 4.130

5.  Brain efflux index to investigate the influence of active efflux on brain distribution of pemetrexed and methotrexate.

Authors:  Li Li; Sagar Agarwal; William F Elmquist
Journal:  Drug Metab Dispos       Date:  2013-01-07       Impact factor: 3.922

6.  High-dose methotrexate with or without rituximab in newly diagnosed primary CNS lymphoma.

Authors:  Matthias Holdhoff; Prakash Ambady; Ahmed Abdelaziz; Guneet Sarai; David Bonekamp; Jaishri Blakeley; Stuart A Grossman; Xiaobu Ye
Journal:  Neurology       Date:  2014-06-13       Impact factor: 9.910

7.  Primary Hypothalamic Lymphoma in an Adult Male: A Case Report and Literature Review.

Authors:  Humam Nisar Tanki; Khursheed Nayil Malik; Rumana Makhdoomi; Shaheen Feroz; Altaf Umaŕ Ramzan
Journal:  Oman Med J       Date:  2018-07

8.  Stereotactic radiosurgery in combination with up-front high-dose methotrexate as a first-line treatment for newly diagnosed primary central nervous system lymphoma.

Authors:  Seiichiro Hirono; Yasuo Iwadate; Yoshinori Higuchi; Toru Serizawa; Osamu Nagano; Tomoro Matsutani; Naokatsu Saeki
Journal:  J Neurooncol       Date:  2015-04-25       Impact factor: 4.130

9.  Primary central nervous system lymphoma.

Authors:  Stephane Doucet; Priya Kumthekar; Jeffrey Raizer
Journal:  Curr Treat Options Oncol       Date:  2013-06

10.  Primary CNS lymphoma treated with radiotherapy in Japan: a survey of patients treated in 2005-2009 and a comparison with those treated in 1985-2004.

Authors:  Yuta Shibamoto; Minako Sumi; Shunsuke Onodera; Haruo Matsushita; Chikao Sugie; Yukihisa Tamaki; Hiroshi Onishi; Eisuke Abe; Masahiko Koizumi; Daisuke Miyawaki; Seiji Kubota; Etsuyo Ogo; Takuma Nomiya; Mitsuhiro Takemoto; Hideyuki Harada; Ippei Takahashi; Yoshio Ohmori; Naoya Ishibashi; Sunao Tokumaru; Kazunori Suzuki
Journal:  Int J Clin Oncol       Date:  2013-12-03       Impact factor: 3.402
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.